Thursday - March 26, 2026

Category Archives: Marketing & Sales

Projecting the Global Drug Delivery Devices Market Size to Expand at a 5.07% CAGR Through 2032, DelveInsight Analysis

Drug Delivery Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. As per DelveInsight’s assessment, The drug delivery devices market is largely driven … Continue reading →

Projecting the Global Cardiac Rhythm Management Devices Market Size to Expand at a 5.23% CAGR Through 2032, DelveInsight Analysis

Cardiac Rhythm Management Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, TThe cardiac rhythm management devices market … Continue reading →

Idiopathic Pulmonary Fibrosis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Idiopathic Pulmonary Fibrosis pipeline constitutes 80+ key companies continuously working towards developing 100+ Idiopathic Pulmonary Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Projecting the Global Peripheral Embolic Protection Devices Market Size to Expand at a significant CAGR Through 2032, DelveInsight Analysis

Peripheral Embolic Protection Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. As per DelveInsight’s assessment, The Peripheral Embolic Protection Devices market is … Continue reading →

Teatime with Miss Liz Unveils April 2026 Global Lineup Championing Stories of Resilience and Transformation

Season 7’s “777” Theme Brings Together Influential Voices Turning Adversity Into Purpose Across Continents. Cornwall, Ontario, Canada – Teatime with Miss Liz, the internationally recognized live interview series known for its raw, thought, provoking conversations, announces its April 2026 Season 7 lineup, … Continue reading →

Myelofibrosis Drug Development Surges: 40+ Pipeline Candidates Across 35+ Companies Reshape Treatment Landscape, analyses DelveInsight

Myelofibrosis Clinical trial Leading Myelofibrosis Companies working in the space include Incyte, Keros Therapeutics, Karyopharm Therapeutics, Celgene, PharmaEssentia, Novartis, SecuraBio, Pharmaxis, AstraZeneca, Cellenkos, Jacobio Pharmaceuticals, Geron Corporation, AbbVie, Sierra Oncology, Galecto Biotech, Kartos Therapeutics, Menarini Group, Telios Pharma, MorphoSys, Roche, … Continue reading →

Global Bispecific Antibody Pipeline Expands Rapidly with 250+ Therapies Across 180+ Companies | DelveInsight Analysis

Bispecific Antibody Clinical Trials Leading Bispecific Antibody Companies working in the space include I-MAB Biopharma, Bristol Myers Squibb, AstraZeneca, BioNTech, Genmab, Compass Therapeutics, Innovent, Regeneron Pharmaceuticals, Aurigene Oncology, Curis, Akeso, Summit Therapeutics, Roche, Merus, Adimab, Creative Biolabs, Amgen, Zymeworks, Xencor, … Continue reading →

Pancreatic Ductal Adenocarcinoma Pipeline Gains Significant Traction with 80+ Companies Advancing Novel Therapies | DelveInsight

Pancreatic Ductal Adenocarcinoma Pipeline Pancreatic Ductal Adenocarcinoma companies include Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix Biosystems, Eucure Biopharma, Panbela Therapeutics, Jeil Pharmaceutical, Elicio Therapeutics, Cend Therapeutics, SignalChem Lifesciences, Bristol Myers Squibb, AstraZeneca, REVOLUTION Medicines, Arcus Biosciences, ZielBio, Surface Oncology, … Continue reading →